Longtime WFSB anchor Mark Zinni is set to return to the airwaves soon, after two unexplained months off the air. Zinni, who ...
Mark Maurer is a reporter on The Wall Street Journal’s CFO Journal team. Based in New York, he writes about corporate finance, accounting, auditing and regulation of companies. Before joining the ...
IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback